Print

IAVI 005

An open-label Phase I study to evaluate safety and immunogenicity of a prime-boost combination of HIV-DNA and MVA vaccines in healthy, HIV-uninfected volunteers

Trial Details:

I Completed
Medical Research Council (MRC)/Oxford October 01, 2001
MVA.HIVA,DNA.HIVA Pox Gag A; DNA Gag A
DNA.HIVA DNA
MVA.HIVA Viral Vector - Pox
United Kingdom 8
http://www.oxavi.org